{
    "Trade/Device Name(s)": [
        "QMS\u00ae Zonisamide",
        "QMS\u00ae Zonisamide Assay",
        "QMS\u00ae Zonisamide Calibrator Set",
        "QMS\u00ae Zonisamide Control Set"
    ],
    "Submitter Information": "Seradyn, Inc.",
    "510(k) Number": "K051211",
    "Predicate Device Reference 510(k) Number(s)": [
        "K955562"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NWM",
        "LAS",
        "DLJ"
    ],
    "Summary Letter Date": "November 18, 2005",
    "Summary Letter Received Date": "November 10, 2005",
    "Submission Date": "November 9, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.3350"
    ],
    "Regulation Name(s)": [
        "Diphenylhydantoin test system"
    ],
    "Analyte Class(es)": [
        "tdm"
    ],
    "Analyte(s)": [
        "Zonisamide"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous particle-enhanced turbidimetric immunoassay",
        "Particle agglutination"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for QMS Zonisamide assay system for quantitative determination of zonisamide in human serum or plasma using automated clinical chemistry analyzers",
    "Indications for Use Summary": "For quantitative determination of zonisamide in human serum or plasma to aid in management of patients treated with zonisamide; calibrator set for calibration and control set for quality control of the assay",
    "fda_folder": "Toxicology"
}